Evidence map›Paper›PMID 38987736›Full record

ArticleBMC cancer2024

Associations between modifiable risk factors and hepatocellular carcinoma: a trans-ancestry Mendelian randomization study.

Xiaoxia Wei, Chenglei Yang, Qiuling Lin, Moqin Qiu, Qiuping Wen, Zihan Zhou, Yanji Jiang, Peiqin Chen, Xiumei Liang, Ji Cao and 4 more

Abstract read
In one paragraph

Article in BMC cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Xiaoxia Wei *Department of Clinical Trial Base, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Chenglei Yang *Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Qiuling LinDepartment of Clinical Trial Base, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Moqin QiuDepartment of Respiratory Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Qiuping WenDepartment of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Zihan ZhouDepartment of Cancer Prevention and Control, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Yanji JiangDepartment of Scientific Research, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Peiqin ChenDepartment of Disease Process Management, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Xiumei LiangKey Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, Guangxi, China.
Ji CaoDepartment of Cancer Prevention and Control, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Juan TangDepartment of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Yuying WeiDepartment of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Hongping Yu *Department of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China. yuhongping@stu.gxmu.edu.cn.
Yingchun Liu *Department of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China. liuyingchun@stu.gxmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPotentially modifiable risk factors for hepatocellular carcinoma (HCC) have been investigated in observational epidemiology studies in East Asian and European populations, whereas the causal associations of most of these risk factors remain unclear.

methodsWe collected genome-wide association summary statistics of 22 modifiable risk factors in East Asians and 33 risk factors in Europeans. Genetic summary statistics of HCC were sourced from the Biobank Japan study (1,866 cases and 195,745 controls) for East Asians, and the deCODE genetics study (406 cases and 49,302 controls) and the UK Biobank (168 cases and 372 016 controls) for Europeans. Two-sample Mendelian randomization (MR) analyses were performed independently for East Asian and European populations.

resultsIn East Asians, genetically predicted alcohol frequency, ever drinkers, aspartate aminotransferase (AST), hypothyroidism, chronic hepatitis B, and chronic hepatitis C, metabolic dysfunction-associated steatotic liver disease (MASLD), and autoimmune hepatitis were significantly associated with an increased HCC risk (P < 0.05/22). Among European population, alanine transaminase, AST, MASLD, percent liver fat, and liver iron content were significantly associated with a higher risk of HCC (P < 0.05/33). The replication dataset and meta-analysis further confirmed these results.

conclusionsAlthough East Asian and European populations have different factors for HCC, their common modifiable risk factors AST and MASLD for HCC, offer valuable insights for targeted intervention strategies to mitigate society burden of HCC.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsMendelian Randomization AnalysisCase-Control StudiesEast Asian PeopleFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansJapanMalePolymorphism, Single NucleotideRisk FactorsWhite PeopleHepatocellular carcinomaMendelian randomizationModifiable risk factorsTrans-ancestry

Identifiers

PMID38987736
PMCPMC11234530

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.